Yale University: Breast Neoplasms trials

The registry lists 26 Breast Neoplasms studies with Yale University as lead sponsor. 1 are open to participants now and 9 have results posted.

Phase 1 4Phase 2 9Phase 3 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant TherapyRecruitingNCT05989347Phase 1
• Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast CancerCompletedNCT04111510Phase 2Results posted
• Lifestyle, Exercise, and Nutrition Study Early After DiagnosisCompletedNCT03314688Not applicableResults posted
• Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast CancerCompletedNCT02489448Phase 1/2Results posted
• Neoadj ph 2 AI Plus Everolimus in Postmenopausal Women w/ ER Pos/HER2 Neg, Low Risk ScoreTerminatedNCT02236572Phase 2Results posted
• Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast CancerCompletedNCT01855828Phase 2Results posted
• 4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast CancerCompletedNCT01646346Not applicableResults posted
• Mammosite Breast Brachytherapy Optimization in the Treatment of Breast CarcinomaCompletedNCT00611624Not applicableResults posted
• Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast CancerTerminatedNCT00461773Phase 2Results posted
• A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast CancerCompletedNCT00411788Phase 2Results posted
• Developing Screening Clinical Breast Examination Implementation Strategies in South AfricaCompletedNCT06233383
• The In4M Study: Integrating 4 Methods to Assess Physical Function in Cancer PatientsCompletedNCT05214144
• Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast CancerCompletedNCT03949270Not applicable
• Objective Evaluation of Paclitaxel/Docetaxel-induced Neuropathy in Breast Cancer PatientsCompletedNCT03872141
• A Clinical Trial Evaluating the Safety and Clinical Activity of Radioiodide (131I-) as a Novel Targeted Therapy for Metastatic Breast Cancer That Overexpresses Functional Na/I SymporterWithdrawnNCT02988648Phase 1/2
• Shave Margins vs. Standard Partial Mastectomy in Breast Cancer PatientsCompletedNCT02772731Not applicable
• A Mail and Video-based Weight Loss Trial in Breast Cancer SurvivorsCompletedNCT02681965Not applicable
• Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) TrialCompletedNCT02256670Not applicable
• Integrating Palliative Care Into Self-Management of Breast CancerCompletedNCT02148575Not applicable
• Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer SurvivorsCompletedNCT02112149Phase 3
• Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast CancerCompletedNCT02057029Not applicable
• Breast Cancer Molecular Analysis ProtocolCompletedNCT01855503
• A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer PatientsCompletedNCT01452399Not applicable
• HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast CancerCompletedNCT00719875Phase 1
• Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerCompletedNCT00002680Phase 2
• Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast CancerCompletedNCT00002679Phase 2